Printer Friendly

HIV therapies may carry health risks.

Widespread use of HIV drugs has dramatically improved the longevity and quality of life for millions of Americans infected with the virus. New studies show, however, that the long-term use of the antiretroviral agents are not without risk.

Investigators recently reported that incidence of heart attack appears to be increased among HIV-infected patients being treated with a protease inhibitor (PI). Dr. Scott Holmberg and his team evaluated about 3,000 HIV-infected patients treated with drugs for one month to several years. Over a period of a few years, hospital records show that 13 patients experienced a heart attack, or myocardial infarction (MI).

"For comparison, we also looked at 3,000 HIV-infected people who never took PI drugs, followed for a similar length of time, and only two of them had an MI," said Dr. Holmberg.

"That's the bad news," he added. "The good news is that it is still not a common event."

Other studies suggest that the use of PIs and another class of antiviral drugs--the nucleoside reverse transcriptase inhibitors (NRTIs)--are also associated with atherosclerosis, liver problems, pancreatitis, and peripheral neuropathy.

Researchers from the Carolina Cardiovascular Biology Center at the University of North Carolina, Chapel Hill, believe that the adverse effects are linked to damage to energy-producing cells of the body called mitochondria.

Fatty acids in the bloodstream are broken down by mitochrondria, the scientists explain in an editorial published in Arteriosclerosis, Thrombosis and Vascular Biology. When these cells are damaged, however, essential reactions do not take place and fat metabolism is altered, potentially leading to high blood levels of the artery-clogging compounds.

Future experiments to test how the drug therapies affect mitochrondria could lead to safer drugs to combat HIV infection in the future. See below for a list of drugs FDA-approved for treating HIV infection.


NRTIs--Ziagen, Trizivir, Videx, Epivir, 3TC, Combivir, Zerit, d4T, Viread, Hivid, Retrovir, AZT

Pls--Agenerase, Crixivan, Kaletra, Viracept, Norvir, Fortovase, Invirase
COPYRIGHT 2003 Benjamin Franklin Literary & Medical Society, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Neighborhood Heart Watch
Author:Zipes, Douglas
Publication:Medical Update
Geographic Code:1USA
Date:Feb 1, 2003
Previous Article:Gauging your risk-new C-reactive protein guidelines.
Next Article:Jack Gardiner: patient number one.

Related Articles
National defibrillation program launched. (Neighborhood Heart Watch).
Success of experimental AIDS drugs offers promise of future therapies. (Full pipeline).
Ask Doctor Cory.
Heart attack risks.
Ask Doctor Cory.
Paths of glory: pathways to wellness, a holistic health center in Boston, mixes up a different HIV cocktail.
Great strides made in universal access to HIV/AIDS treatments.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters